Showing 1 - 10 of 2,087
manufacturers and physicians are uncertain about drug qualities. Our model assumes (i) a representative opinion leader is … (ii) manufacturers use detailing as a means to build/maintain the measure of physicians who are informed of the current … detailing to the current information sets and the measures of well-informed physicians. To illustrate the empirical implications …
Persistent link: https://www.econbiz.de/10014048404
Persistent link: https://www.econbiz.de/10003977328
Persistent link: https://www.econbiz.de/10014451297
Persistent link: https://www.econbiz.de/10014470840
Persistent link: https://www.econbiz.de/10013411880
Persistent link: https://www.econbiz.de/10001235734
"The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work,...
Persistent link: https://www.econbiz.de/10011540424
Persistent link: https://www.econbiz.de/10011548732
Persistent link: https://www.econbiz.de/10011473793